BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2026 3:40:25 AM | Browse: 0 | Download: 0
Publication Name World Journal of Ophthalmology
Manuscript ID 121730
Country Lebanon
Received
2026-03-31 01:08
Peer-Review Started
2026-03-31 01:43
First Decision by Editorial Office Director
2026-04-10 09:30
Return for Revision
2026-04-10 14:55
Revised
2026-04-27 17:54
Publication Fee Transferred
Second Decision by Editor
2026-06-23 02:19
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-06-23 08:36
Articles in Press
2026-06-23 08:36
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-06-30 10:20
Publish the Manuscript Online
2026-09-10 03:40
ISSN 2218-6239 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Ophthalmology
Manuscript Type Retrospective Cohort Study
Article Title Efficacy of nightly 0.01% atropine in controlling myopia progression in Lebanese children: A 24-month retrospective cohort study
Manuscript Source Unsolicited Manuscript
All Author List Adel J Abi Rached, Carina Kasrine El Halabi, Yehya Tlaiss, Michael J Dounia and Anthony Saadeh
ORCID
Author(s) ORCID Number
Yehya Tlaiss http://orcid.org/0009-0003-5266-3690
Funding Agency and Grant Number
Corresponding Author Anthony Saadeh, Assistant Professor, MD, Department of Ophthalmology, Clémenceau Medical Center, Zalka, Beirut 1100, Beyrouth, Lebanon. anthonysaadeh25@gmail.com
Key Words Myopia; Atropine; Pediatric myopia; Myopia control; Low-dose atropine; Myopia progression
Core Tip This is the first study to evaluate nightly 0.01% atropine for myopia control in Lebanese children. Over 24 months atropine-treated eyes demonstrated statistically significantly slower myopic progression than spectacle-only controls at multiple timepoints. No adverse effects were recorded. These findings extend existing evidence to the underrepresented Middle Eastern region. They support low-dose atropine as a safe, accessible and effective option for pediatric myopia management in Lebanon.
Publish Date 2026-09-10 03:40
Citation

Abi Rached AJ, El Halabi CK, Tlaiss Y, Dounia MJ, Saadeh A. Efficacy of nightly 0.01% atropine in controlling myopia progression in Lebanese children: A 24-month retrospective cohort study. World J Ophthalmol 2026; 10(1): 121730

URL https://www.wjgnet.com/2218-6239/full/v10/i1/121730.htm
DOI https://doi.org/10.5318/wjo.121730
Full Article (PDF) WJO-10-121730-with-cover.pdf
STROBE Statement 121730-STROBE-statement.pdf
Manuscript File 121730_Auto_Edited_011129.docx
Answering Reviewers 121730-answering-reviewers.pdf
Audio Core Tip 121730-audio.mp3
Biostatistics Review Certificate 121730-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form 121730-conflict-of-interest-statement.pdf
Copyright License Agreement 121730-copyright-assignment.pdf
Signed Informed Consent Form(s) or Document(s) 121730-informed-consent-statement.pdf
Institutional Review Board Approval Form or Document 121730-institutional-review-board-statement.pdf
Non-Native Speakers of English Editing Certificate 121730-non-native-speakers.pdf
Peer-review Report 121730-peer-reviews.pdf
Scientific Misconduct Check 121730-scientific-misconduct-check.png
CrossCheck Report 121730-crosscheck-report.pdf